Monterola, Julife M.
HRN: 23-06-89 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/23/2023
METRONIDAZOLE 500MG (TAB)
05/23/2023
05/29/2023
PO
500mg
TID
Thickly MSAF, UTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary TractIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes